Wikisage, the free encyclopedia of the second generation, is digital heritage
Gabapentin enacarbil: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
gabapentin enacarbil is a prodrug, originally banned by the FDA. Prescribed in the syndrome of restless legs syndrome and postherpetic neuralgia | gabapentin enacarbil is a prodrug, originally banned by the FDA. Prescribed in the syndrome of restless legs syndrome and postherpetic neuralgia | ||
[[File:Png-Gabapentin.svg.png|thumb|[[gabapentin]]]] | |||
<ref>[https://karmel.miraheze.org/wiki/Gabapentin_enacarbil Karmel Gabapentin enacarbil]</ref> | <ref>[https://karmel.miraheze.org/wiki/Gabapentin_enacarbil Karmel Gabapentin enacarbil]</ref> | ||
==Links== | ==Links== | ||
Revision as of 13:25, 8 June 2019
gabapentin enacarbil is a prodrug, originally banned by the FDA. Prescribed in the syndrome of restless legs syndrome and postherpetic neuralgia
Links
CALDERON, E. et al. Disfunción sexual asociada al uso de gabapentina en el tratamiento del dolor central. Rev. Soc. Esp. Dolor [online]. 2006, vol.13, n.5 [citado 2019-06-08], pp.300-302. Disponible en: <http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-80462006000500004&lng=es&nrm=iso>. ISSN 1134-8046
Further Data
https://tools.wmflabs.org/scholia/topic/Q410352
ATC
|
| References: |
